The Dermatology Digest

FEBRUARY 8, 2024

Psoriasis is also undergoing a revolution with the development of new oral treatments that act like injectable biologics, and this is of interest to patients who do not want a shot,” he says. This will be a game-changer if it pans out and may get us closer to disease cures via optimization of existing biological therapies,” he says.

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

The Dermatology Digest

FEBRUARY 16, 2024

The Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for dupilumab (Dupixent, Sanofi and Regeneron Pharmaceuticals, Inc.) for the treatment of chronic spontaneous urticaria (CSU) in people aged 12 years and older whose disease is not adequately controlled with existing therapy.

Pharmaceutical 36

Pharmaceutical Safety Dermatitis Therapy 36

The Dermatology Digest

MARCH 10, 2024

Jonathan Silverberg, MD, PhD, MPH, Professor of Dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC, discusses the need for a comprehensive treatment approach for CHE. Topical isotretinoin, even when applied to 90% of a patient’s body surface area, showed minimal systemic absorption.

Treatments 36

Treatments Dermatitis Eczema Dermatology 36

The Dermatology Digest

MARCH 13, 2024

Adam Friedman, MD, Professor and Chair of Dermatology at George Washington School of Medicine and Health Sciences in Washington, DC, shares his excitement about chronic spontaneous urticaria (CSU) treatments coming down the pike including remibrutinib, Novartis’ investigational oral Bruton’s tyrosine kinase inhibitor.

Treatments 36

Treatments Dermatitis Dermatology Eczema 36

The Dermatology Digest

MARCH 13, 2024

Silverberg, MD, Chief of Pediatric Dermatology for the Mount Sinai Health System in New York, reviews the rationale for treating Molluscum Contagiosum and shares updates on available treatments including disruptive techniques and the newly approved Zelsuvmi (berdazimer topical gel, 10.3% (Zelsuvmi, Ligand) cantharidin (Ycanth, Verrica).

Treatments 36

Treatments Dermatitis Dermatology Eczema 36

Aesthetics Advisor

SEPTEMBER 3, 2023

Over the past thirty years, modest strides have been made in reducing breast cancer mortality , largely due to increased and improved screening and more effective treatments. These pore-forming, cytotoxic effects underlie interest in melittin as a potential cancer treatment – if it can selectively target cancer cells.

Treatments 36

Treatments Pores Therapy Injections 36

The Dermatology Digest

MAY 2, 2024

Aslan and Zenyaku are teaming up to explore how eblasakimab’s mechanism of action differs from that of other biologic therapies for atopic dermatitis (AD). This new agreement expands upon the commercial agreement that Aslan signed with Zenyaku in June 2023 for the development and commercialization of eblasakimab in Japan.

Pharmaceutical 74

Pharmaceutical Dermatitis Office Clinic 74

Hollywood Institute

JANUARY 2, 2023

Not only is this condition curable, but you aren’t restricted to opioids or other pharmaceutical treatments. Physical therapists incorporate pain management strategies like trigger point massages in their treatment routines because they successfully provide patients with pain relief. What is Trigger Point Therapy?

Therapy 52

Therapy Pharmaceutical Tools Irritation 52

The Dermatology Digest

JULY 22, 2024

“Launching Uzpruvo at the earliest opportunity in Europe’s largest pharmaceutical markets, promotes access by creating competition,” says STADA CEO Peter Goldschmidt in a news release. The post Biosimilar News: Stada, Alvotech Launch the First Ustekinumab Biosimilar Across Europe appeared first on The Dermatology Digest.

Partnerships 36

Partnerships Pharmaceutical Marketing Office 36

The Dermatology Digest

MAY 14, 2024

May is Ichthyosis Awareness Month, and TDD has curated its content on congenital ichthyosis (CI) to help raise awareness of the condition and shine a light on promising new therapies in the pipeline. Each year, more than 16,000 babies are born with some form of ichthyosis.

Pharmaceutical 36

Pharmaceutical Skin Types Dermatology Therapy 36

Aesthetics Advisor

AUGUST 6, 2023

Dr. Nasha Winters is a naturopathic physician who specializes in cancer treatment. If you’re affected by cancer and believe her skills may be helpful, you can have your clinician consult with her to fine-tune your treatment. They’re markers of how advanced the cancer is and how well you’re doing as you’re progressing through treatment.

Treatments 36

Treatments Surgery Consultation Consultations 36

Aesthetics Advisor

FEBRUARY 11, 2024

Millions of people suffer for years or decades without treatment because insurance companies don’t approve screening for autoimmunity until the patient shows significant signs of organ or tissue destruction. At this point, the patient can be prescribed some type of immune-suppressing treatment.

Pharmaceutical 67

Pharmaceutical Diet Clinic Management 67

The Dermatology Digest

DECEMBER 15, 2023

AD: New topicals for kids “The most exciting new research is in the realm of topical therapies for atopic dermatitis (AD) in children,” shares Peter A. In a second study, treatment with ruxolitinib cream under maximum-use conditions was well tolerated in same-aged kids for eight weeks.

Dermatology 36

Dermatology Pharmaceutical Clinic Therapy 36

The Dermatology Digest

DECEMBER 15, 2023

AD: New topicals for kids “The most exciting new research is in the realm of topical therapies for atopic dermatitis (AD) in children,” shares Peter A. In a second study, treatment with ruxolitinib cream under maximum-use conditions was well tolerated in same-aged kids for eight weeks.

Dermatology 36

Dermatology Pharmaceutical Clinic Therapy 36

The Dermatology Digest

AUGUST 14, 2024

Verrica Pharmaceuticals Inc.’s s VP-315 is showing promise in the treatment of basal cell carcinoma, according to Part 2 of its Phase 2 clinical trial. The key preliminary Part 2 results were: No dose-limiting toxicities or Treatment-Related Serious Adverse Events were reported.

Safety 36

Safety Pharmaceutical Clinic Dermatology 36

West Lake Dermatology

OCTOBER 15, 2024

GLP-1’s unique ability to affect both glucose metabolism and appetite makes it a critical hormone in weight management and a target for pharmaceutical treatments aimed at curbing hunger and improving metabolic health. Common side effects include nausea, vomiting, and diarrhea, particularly when starting treatment.

Medical 36

Medical Management Sustainability Pharmaceutical 36

Aesthetics Advisor

FEBRUARY 28, 2024

2 However, as "modern" medicine and the pharmaceutical industry ramped up the health care machine, vitamin C quickly fell out of favor as it is inexpensive, easy to administer and has very few side effects. In other words, as effective as vitamin C is in prevention and treatment, you can’t make money prescribing or manufacturing it.

Vitamin C 36

Vitamin C Pharmaceutical Hospital Therapy 36

Aesthetics Advisor

AUGUST 15, 2023

Disclaimer: We in no way endorse the Joe Tippens Cancer Protocol as a cure for cancer, and as always, you should consult your physician before starting any new medications or treatment plans. However, it is also being used by humans in a cancer treatment method known as the Joe Tippens Protocol. What Is Fenbendazole? chemotherapy?

Therapy 69

Therapy Safety Medical Diet 69

The Dermatology Digest

MARCH 11, 2024

Adding narrowband ultraviolet B phototherapy to treatment with ritlecitinib (Litfulo, Pfizer) in vitiligo may improve patient outcomes.

Dermatitis 69

Dermatitis Eczema Dermatology Pharmaceutical 69

Lipgloss and Aftershave

SEPTEMBER 3, 2024

One of the key goals for every medical + spa skin care professional is to find procedures, products, and devices that can be used in treatment to improve and correct skin issues. Over the past year, L+A has traveled the globe looking for the most effective treatment options to share with our community.

Chemical Peels 52

Chemical Peels Retinol Microneedling Skincare 52

The Dermatology Digest

MARCH 11, 2024

Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, urges viewers to consider AD mimickers, especially when treatment isn’t working.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

OCTOBER 11, 2021

Hopefully in the future, we will be personalizing therapy selection based on clinical phenotypes or biomarkers. Stacking treatments to address multiple contributing mechanistic pathways rather than relying on a single agent will hopefully provide synergistic efficacy.” Thus, the search for biologic options to treat HS has continued.

Pharmaceutical 36

Pharmaceutical Clinic Treatments Consultation 36

The Dermatology Digest

MARCH 11, 2024

Jonathan Silverberg, MD, PhD, MPH, Professor of Dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC, discusses the need for a comprehensive treatment approach for CHE.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 11, 2024

Jonathan Silverberg, MD, PhD, MPH, Professor of Dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC, discusses the need for a comprehensive treatment approach for CHE. Del Rosso, DO, a dermatologist in Las Vegas, NV, and the new President of the American Acne and Rosacea Society.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

Aesthetics Advisor

AUGUST 14, 2023

“If I see this presentation in someone on a statin medication, I will almost always assume the statin is at least a contributing factor and discuss with the patient its removal and replacement with another therapy.” Niacin is the most common and effective treatment that replaces statins, according to Dr. Smith. “Of

Document 36

Document Pharmaceutical Therapy Medical 36

Aesthetics Advisor

AUGUST 22, 2023

In this era of readily available pharmaceutical products for every imaginable ailment, it can be easy to default to the drug store when we need relief. Medieval Persian pharmaceutical manuscripts refer to 1200 types of oxymel. It has not always been that way. Reposted from: [link]

Extractions 36

Extractions Pharmaceutical Diet Ingredients 36

New Age Spa Institute

SEPTEMBER 28, 2023

Our esthetics, massage therapy, and make up students study the history of beauty culture through the ages. New Age Spa Institute recommends: Phytoboost – from the Coterie Fresh ‘N Clear line of pharmaceutical grade skincare prdocuts. It’s the natural oil with the highest amount of vitamin E Book a Galvanic Eye Treatment!

Skincare 52

Skincare Esthetics Esthetician Extractions 52

Aesthetics Advisor

FEBRUARY 11, 2024

Social media posts featuring strange decoctions and peculiar natural treatments flood the internet daily, offering hope to those seeking alternatives to established pharmaceutical approaches. Consult your local community herbalist, naturopathic doctor, or other health care professional for any personalized treatment advice.

Ingredients 36

Ingredients Pharmaceutical Extractions Social Media 36

Aesthetics Advisor

FEBRUARY 7, 2024

Carnosine Protects Against LA-Induced Oxidative Stress One benefit not expounded upon in the Pharmaceuticals paper is carnosine’s ability to reduce LA-induced oxidative stress. Experiments on aged rats showed that therapy with 250 mg/kg/carnosine per day significantly decreased oxidative stress and increased activity of antioxidative enzymes.

Pharmaceutical 36

Pharmaceutical Diet Retinol Injections 36

The Dermatology Digest

FEBRUARY 12, 2024

Alys Pharmaceuticals, Inc. Alys combines six asset-centric Medicxi companies including Al Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics. ” The post Get to Know Alys Pharmaceuticals, Inc. appeared first on The Dermatology Digest.

Pharmaceutical 74

Pharmaceutical Technology Dermatology Medical 74

The Dermatology Digest

MARCH 13, 2024

Single-cell profiling of alopecia areata (AA) can provide key insights into immune-targeting treatment strategies. Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, urges viewers to consider AD mimickers, especially when treatment isn’t working.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, urges viewers to consider AD mimickers, especially when treatment isn’t working. Watch Now Molluscum Contagiosum Treatment Update Nanette B. Silverberg, MD Nanette B.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, urges viewers to consider AD mimickers, especially when treatment isn’t working. Watch Now Molluscum Contagiosum Treatment Update Nanette B. Silverberg, MD Nanette B.

Dermatitis 36

Dermatitis Dermatology Clinic Skin Issues 36

The Dermatology Digest

MARCH 14, 2024

Christopher Bunick, MD, PhD, an associate professor of dermatology at Yale University in New Haven, CT, shares some congenital ichthyosis (CI) cases and discusses the importance of understanding patient and family expectations about CI treatment.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 14, 2024

Chronic spontaneous urticaria (CSU) often has no identifiable trigger and is driven by mast cells, but symptoms are bothersome to patients, highlighting the need for effective treatments, says Jason Hawkes, MD, MS, a dermatologist in Rocklin, CA.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 14, 2024

Watch Now Diagnosing AA: Making the Case for Single-cell Profiling Elizabeth Swanson, MD Single-cell profiling of alopecia areata (AA) can provide key insights into immune-targeting treatment strategies.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 13, 2024

Watch Now Off-label Pearl: Exploring the Role of Narrowband UVB Phototherapy Plus Oral JAK Inhibitors in Vitiligo Emma Guttman-Yassky, MD, PhD Adding narrowband ultraviolet B phototherapy to treatment with ritlecitinib (Litfulo, Pfizer) in vitiligo may improve patient outcomes.

Dermatitis 28

Dermatitis Dermatology Eczema Clinic 28